Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
0.00% $0.0001
America/New_York / 26 apr 2024 @ 15:06
FUNDAMENTALS | |
---|---|
MarketCap: | 0.0009 mill |
EPS: | 7.95 |
P/E: | 0 |
Earnings Date: | May 14, 2024 |
SharesOutstanding: | 8.95 mill |
Avg Daily Volume: | 0.0000 mill |
RATING 2024-04-26 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Sell | |
Return On Asset: | Sell | |
DE: | Strong Buy | |
P/E: | Neutral | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 0 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
N/A |
Company: PE 0 | industry: PE 31.46 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ -0.0009 - 0.0011 ( +/- 1 000.00%) |
ATR Model: 14 days |